“On July 30, BioAmber announced it was seeking court approval to pursue liquidation of its assets as well as alternative investment offers after the company failed to receive any acceptable sales or investment bids by a July 27 deadline. “
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.